Inactivation of nuclear factor κB by MIP-based drug combinations augments cell death of breast cancer cells

BACKGROUND: Drug combination therapy to treat cancer is a strategic approach to increase successful treatment rate. Optimizing combination regimens is vital to increase therapeutic efficacy with minimal side effects. MATERIALS AND METHODS: In the present study, we evaluated the in vitro cytotoxicity...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Des Devel Ther
Main Authors: Subramaniam, Menaga, Liew, Su Ki, In, Lionel LA, Awang, Khalijah, Ahmed, Niyaz, Nagoor, Noor Hasima
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5935191/
https://ncbi.nlm.nih.gov/pubmed/29750018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S141925
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados